Core Viewpoint - Zoetis forecasts strong adjusted profit and revenue for 2026, driven by steady demand in its companion-animal portfolio and resilient international markets, despite softer trends in the U.S. [1] Financial Performance - Zoetis expects adjusted earnings of $7.00 to $7.10 per share for 2026, exceeding analysts' estimate of $6.80 [1] - Projected revenue for 2026 is between $9.83 billion and $10.03 billion, with the midpoint surpassing estimates of $9.91 billion [1] - The company's adjusted profit per share for the recent quarter was $1.48, above estimates of $1.40 [1] - Revenue for the recent quarter rose 3% to $2.39 billion, exceeding estimates of $2.36 billion [1] Segment Performance - Revenue from the companion-animal segment increased by 2% to $1.60 billion [1] - Livestock revenue rose by 4% to $756 million [1] Market Reaction - Shares of Zoetis rose by 4.4% in premarket trading following the forecast announcement [1] - Analyst Chris Schott from J.P. Morgan noted that investor expectations were low prior to the update due to competition concerns, and the forecast should alleviate some of these worries [1]
Zoetis forecasts strong 2026 profit, revenue on steady pet‑medicine demand